Retatrutide 20 MG

### Triple Receptor Agonist for Advanced Metabolic Research

Retatrutide (20 MG) is a next-generation multi-agonist synthetic peptide that simultaneously engages the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCGR) receptor pathways.

Synthesized using advanced solid-phase peptide synthesis (SPPS), this compound is produced to an analytical purity exceeding 99.0%. Lyophilized under high-vacuum conditions to produce a stable white cake with minimal residual moisture.

### Analytical & Research Scope

• **Target Receptors**: GIP Receptor (GIPR), GLP-1 Receptor (GLP-1R), Glucagon Receptor (GCGR).

• **Primary Research Domains**: Multi-incretin signaling kinetics, energy balance pathways, mitochondrial substrate oxidation modeling, and lipid homeostasis.

• **Application**: For in-vitro cell receptor binding assays and non-clinical laboratory models only.

### Chemical Specifications

• **Molecular Formula**: C221H342N56O67S2

• **Molecular Weight**: ~4845.5 g/mol

• **Purity**: ?99.0% (Reversed-Phase HPLC)

• **Physical Form**: Sterile Lyophilized Cake

• **Counter Ion**: Trifluoroacetate (TFA) / Acetate

• **Endotoxin Content**: <0.5 EU/mg

### Storage & Handling Recommendations

• **Lyophilized State**: Store at -20??C (-4??F) in a desiccated, light-protected container for up to 24 months.

• **Reconstituted State**: Reconstitute with 1-2 mL of sterile Bacteriostatic Water. Maintain at 2??C to 8??C (36??F to 46??F) and use within 28 days.

• **Handling Note**: Swirl gently upon adding diluent; do not vortex or shake vigorously.